Skip to main content
Alpa Laboratories Limited logo

Alpa Laboratories Limited — Investor Relations & Filings

Ticker · ALPA ISIN · INE385I01010 LEI · 335800O2RIWENG8KPR59 BSE.NS Manufacturing
Filings indexed 321 across all filing types
Latest filing 2022-10-01 Regulatory Filings
Country IN India
Listing BSE.NS ALPA

About Alpa Laboratories Limited

https://alpalabs.in/

Alpa Laboratories Limited specializes in the development and manufacture of a broad range of pharmaceutical formulations for human and veterinary applications. The company's core capabilities include the production of small volume parenterals, such as liquid and dry powder injections, alongside solid orals like tablets and capsules. Its portfolio further extends to topical preparations including ointments, creams, gels, and ophthalmic/otic drops. Utilizing WHO-GMP certified manufacturing units, the organization provides extensive contract manufacturing and research services to prominent global healthcare brands. The company serves diverse therapeutic segments, including anti-infectives, analgesics, and nutritional supplements, maintaining a robust presence in both domestic and international markets through a commitment to stringent quality standards and technical excellence.

Recent filings

Filing Released Lang Actions
Annual General Meeting
Regulatory Filings
2022-10-01 English
Annual General Meeting
Regulatory Filings
2022-09-29 English
Book Closure
Regulatory Filings
2022-09-09 English
Outcome of Board Meeting
Regulatory Filings
2022-08-13 English
Board Meeting — Financial results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about a scheduled Board Meeting to consider the unaudited financial results for the quarter ended June 30, 2022, and to approve the Notice of the 34th Annual General Meeting. It does not contain the financial results themselves, only an announcement of the meeting where these results will be considered. The document length is only 1664 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about an upcoming board meeting and financial results consideration, not the financial report itself or a detailed presentation.
2022-08-02 English
Related Party Transaction
Regulatory Filings
2022-07-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.